S2Medical ABOSTO:S2M Current Ratio is 0.56 as of Dec. 2025, which is 76% below its 10-year median of 2.34. The stock has 3 warning signs investors should review. Among 854 Medical Devices & Instruments companies, S2Medical AB ranks worse than 94.38% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. S2Medical AB's current ratio for the quarter that ended in Dec. 2025 was 0.56.
S2Medical AB has a current ratio of 0.56. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If S2Medical AB has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for S2Medical AB's Current Ratio or its related term are showing as below:
OSTO:S2M'
s Current Ratio Range Over the Past 10 Years
Min: 0.44 Med: 2.34 Max: 10.45
Current: 0.56
During the past 10 years, S2Medical AB's highest Current Ratio was 10.45. The lowest was 0.44. And the median was 2.34.
OSTO:S2M's Current Ratio is ranked worse than 94.38% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 2.49
vs OSTO:S2M: 0.56
S2Medical AB (OSTO:S2M) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
S2Medical AB Current Ratio Related Terms
S2Medical AB Current Ratio Historical Data
* Premium members only.
The historical data trend for S2Medical AB's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:S2M vs ISRG, BDX, MDLN: Current Ratio Comparison
For the Medical Instruments & Supplies subindustry, S2Medical AB's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
S2Medical AB Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, S2Medical AB's Current Ratio distribution charts can be found below:
* The bar in red indicates where S2Medical AB's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
S2Medical AB (OSTO:S2M) has a Current Ratio of 0.56 as of Dec. 2025. This is 76% below median its historical median of 2.34. Over the past decade, S2Medical AB's Current Ratio has ranged from 0.44 to 10.45. According to the industry distribution chart, S2Medical AB ranks #806 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 94.4%.
Is S2Medical AB's Current Ratio too high?
S2Medical AB's current Current Ratio of 0.56 is 76% below median its 10-year median of 2.34. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 10.45. The Medical Devices & Instruments industry median Current Ratio is 2.49. S2Medical AB's value of 0.56 is 77.5% below this industry median. Based on the distribution chart, S2Medical AB ranks #806 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does S2Medical AB's Current Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, S2Medical AB ranks #806 out of 854 companies for Current Ratio. This places S2Medical AB in the lower half of its industry. The industry median Current Ratio is 2.49. S2Medical AB's value of 0.56 is 77.5% below this benchmark. Historically, S2Medical AB's own Current Ratio has ranged from 0.44 to 10.45 over the past decade. While the company's 10-year median is 2.34 vs. the industry median of 2.49, S2Medical AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. S2Medical AB's current Current Ratio of 0.56 is 77.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. S2Medical AB's current Current Ratio is 0.56, which is 76% below median its own 10-year median of 2.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is S2Medical AB stock overvalued right now?
Based on GuruFocus' analysis, S2Medical AB (OSTO:S2M) is currently considered Possible Value Trap. The stock's GF Value™ is kr0.01, compared to a current price of kr0.01 — trading 48% below its estimated fair value. The current Current Ratio is 0.56, which is 76% below median its 10-year median of 2.34 and 77.5% below the Medical Devices & Instruments industry median of 2.49. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For S2Medical AB (OSTO:S2M), the current Current Ratio is 0.56 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
S2Medical AB is a research-intensive MedTech company from Sweden. The company develops products within the entire wound healing process from debridement and granulation to re-epithelialization. products for the initial phase of a wound's healing process until the end, when the wound is completely healed. S2Medical also has in its portfolio the product NoSmell for odor removal which is procured in several different Swedish healthcare regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:S2M has been successfully added to your 